Epidemiology of Sexually Transmitted Infections in Rural Southwestern Haiti: The Grand'Anse Women's Health Study

Jobe, Kathleen A.; Downey, Robert F.; Hammar, Donna; Slyke, Lori Van; Schmidt, Terri A.

doi:10.4269/ajtmh.13-0762

Cited by 13 publications

(9 citation statements)

References 13 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The median study sample size was 399 in women (IQR: 309-1719) and 371 in men (IQR: 180-5749). All studies involved NAAT screening of urine (n=4) [ 16 , 44 , 45 , 49 ] and urogenital swab samples (n=7) [ 17 , 46 – 48 , 50 , 51 , 53 ] for women (clinical specimen not specified, n=1 [ 52 ]), and urine (n=3) [ 17 , 48 , 49 ] for men (clinical specimen not specified, n=1 [ 80 ]).…”

Section: Resultsmentioning

confidence: 99%

Gonorrhoea: a systematic review of prevalence reporting globally

Whelan¹,

Abbing‐Karahagopian²,

Serino³

et al. 2021

BMC Infect Dis

View full text Add to dashboard Cite

Background The World Health Organization (WHO) recommends periodic gonorrhoea prevalence assessments in the general population or proxies thereof (including pregnant women, women attending family planning clinics, military recruits, and men undergoing employment physicals for example) and in population groups at increased risk, including men-who-have-sex-with-men (MSM) and sex workers. Method We evaluated reported prevalence data, including estimates from proxy general population samples to reflect the WHO recommendations. We describe the outcomes from the general population country-by-country and extend previous reviews to include MSM, sex workers, and extragenital infections. Result and conclusion In our systematic search, 2015 titles were reviewed (January 2010–April 2019) and 174 full-text publications were included. National, population-based prevalence data were identified in only four countries (the United States of America, the United Kingdom, Peru, New Caledonia) and local population-based estimates were reported in areas within five countries (China, South Africa, Brazil, Benin, and Malawi). The remaining studies identified only reported test positivity from non-probability, proxy general population samples. Due to the diversity of the reviewed studies, detailed comparison across studies was not possible. In MSM, data were identified from 64 studies in 25 countries. Rectal infection rates were generally higher than urogenital or pharyngeal infection rates, where extragenital testing was conducted. Data on sex workers were identified from 41 studies in 23 countries; rates in female sex workers were high. Current prevalence monitoring was shown to be highly suboptimal worldwide. Serial prevalence monitoring of critical epidemiological variables, and guidelines to optimize prevalence study conduct and reporting beyond antenatal settings are recommended.

show abstract

Section: Resultsmentioning

confidence: 99%

Gonorrhoea: a systematic review of prevalence reporting globally

Whelan¹,

Abbing‐Karahagopian²,

Serino³

et al. 2021

BMC Infect Dis

View full text Add to dashboard Cite

show abstract

“…Prior studies looking at the prevalence of STI in the general populations have focused mainly on women attending antenatal services in Haiti: a relatively high prevalence of CT and NG was reported in rural Artibonite in 1996 (2.3% had gonorrhoea (11/475) and 10% had chlamydia (51/475))18 and in Cite Soleil, an urban slum in 1994 (12% (110/897) had gonococcal or chlamydial cervical infection (or both)) 18 19. A lower prevalence was reported among women accessing antenatal services in rural Central Plateau in 2003 (4.8% had chlamydia (84/1742), 1.3% had gonorrhoea (23/1727)) and in rural Grand’Anse in 2012 (1.9% had chlamydia (2/104), and 1% had gonorrhoea in 1% (1/104))20 21 which might suggest a geographic variation in the distribution of CT and NG in Haiti.…”

Section: Discussionmentioning

confidence: 99%

Prevalence ofNeisseria gonorrhoeaeandChlamydia trachomatisin men having sex with men in Port-au-Prince, Haiti: a cross-sectional study

Louis¹,

Galbaud²,

Leonard³

et al. 2020

BMJ Open

View full text Add to dashboard Cite

ObjectivesOver the last 15 years, the prevalence of HIV in Haiti has stabilised to around 2.0%. However, key populations remain at higher risk of contracting HIV and other sexually transmitted infections (STIs). The prevalence of HIV is 12.9% among men having sex with men (MSM). There is limited information about the prevalence of other STI in the Haitian population in general and even less among key populations. We assessed the burden ofChlamydia trachomatis(CT) andNeisseria gonorrhoeae(NG) and risk factors for infections among MSM in Haiti.MethodsA cross-sectional study was conducted. MSM were recruited from seven health facilities in Port-au-Prince. All samples were tested by nucleic acid amplification test, using GeneXpert. A survey was administered to the participants to collect socio-demographic, clinical and risk behaviour data.ResultsA total of 216 MSM were recruited in the study. The prevalence rates of CT and NG were 11.1% and 16.2%, respectively. CT NG co-infections were found in 10/216 (4.6%) of the participants. There were 39 MSM with rectal STI compared with 17 with genital infections. Participants between 18–24 and 30–34 years old were significantly more likely to be infected with NG than those aged 35 years or older (OR: 22.96, 95% CI: 2.79 to 188.5; OR: 15.1, 95% CI: 1.68 to 135.4, respectively). Participants who never attended school or had some primary education were significantly more likely to be infected with NG than those with secondary education or higher (OR: 3.38, 95% CI: 1.26 to 9.07). People tested negative for HIV were significantly more likely to be infected with CT than people living with HIV/AIDS (OR: 3.91, 95% CI: 1.37 to 11.2).ConclusionsPeriodic risk assessment and testing for STI should be offered in Haiti as part of a comprehensive strategy to improve the sexual health of key populations.

show abstract

“…Apesar de nenhum estudo controlado ter conseguido provar a relação entre a transmissão sexual e a eficácia do tratamento dos parceiros na prevenção das infecções de repetição e atualmente a CVV não ser considerada doença sexualmente transmissível (DST) 11 , nossos resultados, como os de outros pesquisadores, sugerem que o parceiro sexual representa papel relevante na candidíase vulvovaginal 27,28,[30][31][32][33][34][35] e que seu tratamento em conjunto com a terapia instituída na mulher, nas complicações e/ou recorrências, deva ser sempre considerado 29,31,32 .…”

Section: Discussionunclassified